Crossref
Propofol + midazolam vs propofol alone: similar risk of propofol infusion syndrome
Reactions Weekly · 09.05.2026 · 2109 (1) · 11-11
DOI: 10.1007/s40278-026-94512-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reactions Weekly, online erschienen am 09.05.2026. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Propofol + midazolam vs propofol alone: similar risk of propofol infusion syndrome. Reactions Weekly, 2109(1), 11-11. https://doi.org/10.1007/s40278-026-94512-3
Vancouver
Propofol + midazolam vs propofol alone: similar risk of propofol infusion syndrome. Reactions Weekly. 2026;2109(1):11-11. doi:10.1007/s40278-026-94512-3
BibTeX
@article{euvimed2026,
title = {Propofol + midazolam vs propofol alone: similar risk of propofol infusion syndrome},
journal = {Reactions Weekly},
year = {2026},
volume = {2109},
number = {1},
pages = {11--11},
doi = {10.1007/s40278-026-94512-3}
}
EUVIMED